Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Did Medtronic (NYSE:MDT) Trade 9.1 Times Normal Volume After MiniMed Exchange Proration of 18.289133%?

Medtronic announced on October 14 the final results of its exchange offer for MiniMed Group, which expired on October 9 and was oversubscribed, with 297,521,390 Medtronic ordinary shares validly tendered. Medtronic accepted 55,032,401 shares in exchange for all of its remaining 252,813,348 MiniMed shares, …

Vinay Lochav | 14 October 2026

Can AbbVie (NYSE:ABBV) Back a USD 1.73 Quarterly Dividend After Lowering Third-Quarter EPS Guidance to USD 3.73 to USD 3.77?

AbbVie's board declared on September 10 a quarterly cash dividend of USD 1.73 per share, payable on November 16 to stockholders of record on October 15, and the company has raised its dividend by more than 330% since its inception in 2013. On October …

Vinay Lochav | 14 October 2026

Why Picard Medical (NYSE American:PMI) Is in Focus After Latest Artificial Heart Device Results

● Gross margin reached about 20.9%, against a gross loss a year earlier.

Nitish Kishor | 14 October 2026

Why China SXT Pharmaceuticals (NASDAQ:SXTC) Is in Focus After Its Share Consolidation

● Class A shares outstanding fall from about 105.7 million to about 1.32 million.

Nitish Kishor | 14 October 2026

How Are Rate Changes Reshaping Humana (NYSE:HUM) Medicare Advantage Margins?

Humana Inc. (NYSE:HUM) stands as one of the United States’ premier managed healthcare organizations and health insurance providers, maintaining an influential constituent presence within the S&P 500 index. Headquartered in Louisville, Kentucky, Humana has distinguished itself by executing a focused, pure-play strategic commitment to …

Nitish Kishor | 14 October 2026

Moderna (NASDAQ:MRNA) Stock: Pipeline Readouts Shape the Post-Pandemic Pivot

Moderna, Inc. (NASDAQ:MRNA), a pioneer in messenger RNA (mRNA) therapeutics and biotechnology vaccines headquartered in Cambridge, Massachusetts, stands as an established biopharmaceutical constituent within major US market indices. Having achieved historic scientific and commercial success by delivering one of the world’s first approved COVID-19 …

Nitish Kishor | 14 October 2026

What Do AbbVie (NYSE:ABBV) Results Say About Skyrizi and Rinvoq Replacing Humira, and What Does Apogee Change?

● Skyrizi and Rinvoq together exceeded $8.0 billion, while Humira fell 35.9%.

Nitish Kishor | 14 October 2026

When Did Johnson & Johnson (NYSE:JNJ) Book a Talc-Related Charge, and How Did Third-Quarter Sales Growth Compare?

● GAAP net earnings were $210 million, down 95.9%, after a one-time special charge.

Nitish Kishor | 14 October 2026

Why Did Eli Lilly (NYSE:LLY) Raise 2026 Revenue Guidance While Prices Fell?

● Realised prices fell 13%, partly offsetting the volume increase.

Nitish Kishor | 14 October 2026

What Do Acquisition Charges Mean for Merck (NYSE:MRK), a Dow Jones Member, as Keytruda Grows?

● A $5.7 billion charge relating to the Terns acquisition drove the accounting loss.

Nitish Kishor | 14 October 2026
Support

Hi! How can we help you today?

Loading…